- Investor's Business Daily•1 hour ago
Eli Lilly could benefit to the tune of $1.7 billion in 2025 on expanded Jardiance sales after the FDA approved another indication.
- CNBC•1 hour ago
The agency said Friday that it approved a new indication for a drug marketed by Eli Lilly and Boehringer Ingelheim.
LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance
Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||67.71 x 600|
|Ask||67.72 x 2600|
|Day's Range||65.96 - 68.39|
|52 Week Range||64.18 - 88.16|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||29.45|
|Dividend & Yield||2.04 (3.04%)|
|1y Target Est||N/A|